Authors:
VANHALTEREN HK
VANDERLINDEN PWG
BURGERS JA
BARTELINK AKM
Citation: Hk. Vanhalteren et al., DISCONTINUATION OF VENOM IMMUNOTHERAPY - REPLY, Journal of allergy and clinical immunology, 102(4), 1998, pp. 703-704
Authors:
BREIMERLINCKENS EM
VREUGDENHIL G
KEUNING JJ
VANHALTEREN HK
VINGERHOETS AJJM
Citation: Em. Breimerlinckens et al., FACTORS DETERMINING THE APPRECIATION OF TREATMENT BY ADVANCED COLORECTAL-CANCER PATIENTS, European journal of cancer, 33, 1997, pp. 263-263
Citation: Hk. Vanhalteren et al., 5-FLUOROURACIL-BASED TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA OUTSIDE CLINICAL-TRIALS - IMPORTANCE OF LIMITED TOXICITY, Annals of oncology, 8(2), 1997, pp. 203-203
Authors:
VANHALTEREN HK
WAGENER DJT
VREUGDENHIL G
PUNT CJA
Citation: Hk. Vanhalteren et al., ADVANCED COLORECTAL-CANCER, REFRACTORY TO INFUSIONAL FLUOROURACIL TREATMENT - EFFICACY OF 2ND LINE FLUOROURACIL IN COMBINATION WITH A DIFFERENT BIOCHEMICAL MODULATION, Anticancer research, 17(4A), 1997, pp. 2715-2719
Authors:
VANHALTEREN HK
VANDERLINDEN PWG
BURGERS JA
BARTELINK AKM
Citation: Hk. Vanhalteren et al., DISCONTINUATION OF YELLOW JACKET VENOM IMMUNOTHERAPY - FOLLOW-UP OF 75 PATIENTS BY MEANS OF DELIBERATE STING CHALLENGE, Journal of allergy and clinical immunology, 100(6), 1997, pp. 767-770
Authors:
VANHALTEREN HK
VANDERLINDEN PWG
BURGERS SA
BARTELINK AKM
Citation: Hk. Vanhalteren et al., HYMENOPTERA STING CHALLENGE OF 348 PATIENTS - RELATION TO SUBSEQUENT FIELD STINGS, Journal of allergy and clinical immunology, 97(5), 1996, pp. 1058-1063
Authors:
VANHALTEREN HK
TAAL BG
VANTINTEREN H
VANLEEUWEN FE
Citation: Hk. Vanhalteren et al., RISK-FACTORS FOR THE DEVELOPMENT OF ESOPHAGEAL CANCER AS A 2ND PRIMARY TUMOR, European journal of cancer, 31A(11), 1995, pp. 1836-1839
Authors:
VANHALTEREN HK
TOP B
MOOI WJ
BALM AJM
RODENHUIS S
Citation: Hk. Vanhalteren et al., ASSOCIATION OF H-RAS MUTATIONS WITH ADENOCARCINOMAS OF THE PAROTID-GLAND, International journal of cancer, 57(3), 1994, pp. 362-364